All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY810 | Anti-KCNMB4 (CBLY1-055) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLY1-055 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY811 | Anti-KCNMB4 (CBLY1-056) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLY1-056 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY812 | Anti-KCNMB4 (1G7) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1G7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY813 | Anti-KCNMB4 (S18A-3) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | S18A-3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY956 | Anti-KCNMB4 (L18A-3) h(41BB-CD3ζ) CAR, pCDCAR1 | Mammal | L18A-3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2450 | Anti-KCNMB4(CBLY1-055) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLY1-055 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2451 | Anti-KCNMB4(CBLY1-056) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLY1-056 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2452 | Anti-KCNMB4(1G7) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1G7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2453 | Anti-KCNMB4(S18A-3) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | S18A-3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2596 | Anti-KCNMB4(L18A-3) h(CD28-CD3ζ) CAR, pCDCAR1 | Mammal | L18A-3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION